Target intelligence / Profile preview

Vitamin B12 transport and carrier proteins

Molecular classification
Transporter, Carrier protein, Receptor
01

Overview

Vitamin B12 transport and carrier proteins constitute a specialized multi-protein system essential for the absorption, systemic circulation, and cellular uptake of cobalamin (Vitamin B12). The system primarily involves three binding proteins: Haptocorrin (TCN1), which protects B12 in the stomach; Intrinsic Factor (GIF), which facilitates absorption in the ileum; and Transcobalamin II (TCN2), which delivers the vitamin to peripheral tissues via the CD320 receptor (Nielsen et al., 2012). This pathway is critical because humans cannot synthesize B12 and must rely on efficient transport to support DNA synthesis and neurological function (Mucha et al., 2021). Defects in these proteins or their receptors lead to severe clinical conditions such as pernicious anemia and megaloblastic anemia. Therapeutically, these proteins are targeted for B12 supplementation and are increasingly explored as vehicles for the targeted delivery of drugs and imaging agents, particularly in oncology where B12 receptors are often overexpressed (Gupta et al., 2008). Recent research also highlights the importance of these transport proteins as biomarkers for subclinical deficiency and cognitive decline (Green et al., 2025).

Other names
TranscobalaminsCobalamin-binding proteinsR-bindersVitamin B12-binding proteinsCobalamin transport system
02

Mechanism of action

Sequential binding and transport of cobalamin through the gastrointestinal tract and bloodstream, followed by receptor-mediated endocytosis into target cells via specific receptors like CD320 and the Cubam complex.

03

Biological functions

Vitamin B12 absorptionVitamin B12 circulationCellular uptake of cobalaminProtection of cobalamin from degradationRenal reabsorption of cobalamin
04

Disease associations

Pernicious anemiaVitamin B12 deficiencyMegaloblastic anemiaNeurological diseaseImerslund-Gräsbeck syndromeCognitive decline
05

Safety considerations

Malabsorption due to intrinsic factor deficiencyAutoimmune interference (anti-intrinsic factor antibodies)Drug-induced deficiency (e.g., Metformin, Proton-pump inhibitors)Competition with inactive cobalamin analoguesGenetic defects in transport proteins (e.g., TCN2 mutations)
06

Interacting drugs

Cyanocobalamin

5 more in the full profile.

07

Biomarkers

Holotranscobalamin (HoloTC)Methylmalonic acid (MMA)Homocysteine (Hcy)Total serum vitamin B12

Beyond the preview

Go deeper on Vitamin B12 transport and carrier proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamin B12 transport and carrier proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call